Literature DB >> 12517300

The role of antibiotic treatment alone for the management of Brucella endocarditis in adults: a case report and literature review.

Ali Mert1, Funda Kocak, Resat Ozaras, Fehmi Tabak, Muammer Bilir, Serdar Kucukuglu, Recep Ozturk, Yildirim Aktuglu.   

Abstract

Endocarditis is a rare complication of brucellosis but it is the main cause of the mortality in this disease. The accepted treatment for Brucella endocarditis (BE) is a combination of valve replacement and antibiotics. Conservative antibiotic treatment alone is not recommended by most of the authors as it is considered ineffective and increase the risk of fatality. In our literature search, we found 14 adult patients with BE treated only with antibiotics with a favorable outcome. In this report, we described a patient treated with antibiotics alone and reviewed the literature. Depending on the data from the growing literature and our patient we suggest that in selected patients with BE who do not have congestive heart failure, valvular destruction, abscess formation, or a prosthetic valve, conservative antibiotic treatment may be a valid alternative to surgery.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12517300

Source DB:  PubMed          Journal:  Ann Thorac Cardiovasc Surg        ISSN: 1341-1098            Impact factor:   1.520


  25 in total

1.  Brucella endocarditis in prosthetic valves.

Authors:  Sascha Al Dahouk; Thomas Schneider; Andreas Jansen; Karsten Nöckler; Herbert Tomaso; Ralf M Hagen; Holger C Scholz; Martin Rudwaleit; Heinrich Neubauer; Andreas J Morguet
Journal:  Can J Cardiol       Date:  2006-09       Impact factor: 5.223

Review 2.  Quinolones for treatment of human brucellosis: critical review of the evidence from microbiological and clinical studies.

Authors:  Matthew E Falagas; Ioannis A Bliziotis
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

3.  Tissue culture positive prosthetic aortic valve Brucella endocarditis.

Authors:  M I Tasbakan; T Yamazhan; B Arda; H Pullukcu; O R Sipahi; C Buke; S Ulusoy
Journal:  Ir J Med Sci       Date:  2006 Apr-Jun       Impact factor: 1.568

4.  Re: P Mathieu, JP Després, P Pibarot. The 'valvulo-metabolic' risk in calcific aortic valve disease. Can J Cardiol 2007;23(Suppl B): 32B-39B.

Authors:  John Morphet
Journal:  Can J Cardiol       Date:  2008-06       Impact factor: 5.223

5.  Brucella endocarditis - a series of five case reports.

Authors:  I Tammi Raju; Rachana Solanki; A N Patnaik; R C Barik; N R Kumari; A S Gulati
Journal:  Indian Heart J       Date:  2013-01-02

6.  Brucella arteritis: clinical manifestations, treatment, and prognosis.

Authors:  Jesica A Herrick; Robert J Lederman; Brigit Sullivan; John H Powers; Tara N Palmore
Journal:  Lancet Infect Dis       Date:  2014-01-28       Impact factor: 25.071

7.  Human brucellosis in a nonendemic country: a report from Germany, 2002 and 2003.

Authors:  S Al Dahouk; K Nöckler; A Hensel; H Tomaso; H C Scholz; R M Hagen; H Neubauer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-07       Impact factor: 3.267

Review 8.  The current therapeutical strategies in human brucellosis.

Authors:  Mile Bosilkovski; Fariba Keramat; Jurica Arapović
Journal:  Infection       Date:  2021-03-01       Impact factor: 3.553

9.  Brucella endocarditis: an occupational hazard!

Authors:  Sanjeev Kumar Agarwal; Ali Raza Rajani; Kosar Hussain; Mangesh Manoharrao Dande
Journal:  BMJ Case Rep       Date:  2013-04-22

Review 10.  Medical versus medical and surgical treatment for brucella endocarditis.

Authors:  Maryam Keshtkar-Jahromi; Seyed-Mostafa Razavi; Sharareh Gholamin; Marzieh Keshtkar-Jahromi; Mian Hossain; Mohammad M Sajadi
Journal:  Ann Thorac Surg       Date:  2012-10-26       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.